Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000494:pharmacology; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology*; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D011241:Prednisone / Q000494:pharmacology; D013053:Spectrophotometry; D013936:Thymidine / Q000502:physiology; D013997:Time Factors; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D003561:Cytarabine; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D013936:Thymidine; D008727:Methotrexate; D003630:Daunorubicin